{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T20:54:29Z","timestamp":1792356869361,"version":"4.4.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/bf03401332","type":"journal-article","created":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T09:30:48Z","timestamp":1533720648000},"page":"163-181","source":"Crossref","is-referenced-by-count":59,"title":["Vitamin D and diabetes mellitus"],"prefix":"10.1007","volume":"13","author":[{"given":"Chittari Venkata","family":"Harinarayan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,1]]},"reference":[{"key":"BF03401332_CR1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/nu4010052","volume":"4","author":"CE Chagas","year":"2012","unstructured":"Chagas CE, Borges MC, Martini LA, Rogero MM, 2012 Focus on vitamin D, inflammation and type 2 diabetes. Nutrients 4: 52\u201367.","journal-title":"Nutrients"},{"key":"BF03401332_CR2","unstructured":"IDF diabetes atlas. International Diabetes Federation 2009 Available at: https:\/\/doi.org\/www.idf.org\/diabetesatlas\/5e\/ the-global-burden last accessed on 30\/09\/2012."},{"key":"BF03401332_CR3","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1600-0625.2007.00570.x","volume":"16","author":"J Reichrath","year":"2007","unstructured":"Reichrath J, 2007 Exp Dermatol 16: 618\u2013625.","journal-title":"Exp Dermatol"},{"key":"BF03401332_CR4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/ajcn\/79.3.362","volume":"79","author":"MF Holick","year":"2004","unstructured":"Holick MF, 2004 Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79: 362\u2013371.","journal-title":"Am J Clin Nutr"},{"key":"BF03401332_CR5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1210\/jcem-67-2-373","volume":"67","author":"AR Webb","year":"1988","unstructured":"Webb AR, Kline L, Holick MF, 1988 Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67: 373\u2013378.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03401332_CR6","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1210\/endo-124-2-655","volume":"124","author":"DD Bikle","year":"1985","unstructured":"Bikle DD, Pillai S, Gee E, Hincenbergs M, 1985 Regulation of 1,25-dihydroxyvitamin D production in human keratinocytes by interferon-gamma. Endocrinology 124: 655\u2013660.","journal-title":"Endocrinology"},{"key":"BF03401332_CR7","doi-asserted-by":"crossref","first-page":"30381","DOI":"10.1074\/jbc.271.48.30381","volume":"271","author":"Y Ohyama","year":"1996","unstructured":"Ohyama Y, Ozono K, Uchida M, et al, 1996 Functional assessment of two vitamin D-responsive elements in the rat 25-hydroxyvitamin D3 24-hydroxylase gene. J Biol Chem 271: 30381\u201330385.","journal-title":"J Biol Chem"},{"issue":"Suppl 6","key":"BF03401332_CR8","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/ajcn\/80.6.1689S","volume":"80","author":"HF DeLuca","year":"2004","unstructured":"DeLuca HF, 2004 Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80: Suppl 6: 1689\u20131696.","journal-title":"Am J Clin Nutr"},{"key":"BF03401332_CR9","first-page":"321","volume":"20","author":"NJ McKenna","year":"1999","unstructured":"McKenna NJ, Lanz RB, O\u2019Malley BW, 1999 Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20: 321\u2013344.","journal-title":"Endocr Rev"},{"key":"BF03401332_CR10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1124\/pr.54.3.431","volume":"54","author":"B Razani","year":"2002","unstructured":"Razani B, Woodman SE, Lisanti MP, 2002 Caveolae: from cell biology to animal physiology. Pharmacol Rev 54: 431\u2013467.","journal-title":"Pharmacol Rev"},{"key":"BF03401332_CR11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.tibs.2004.10.005","volume":"29","author":"DE Prosser","year":"2004","unstructured":"Prosser DE, Jones G, 2004 Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 29: 664\u2013673.","journal-title":"Trends Biochem Sci"},{"key":"BF03401332_CR12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ecl.2010.02.013","volume":"39","author":"T Takiishi","year":"2010","unstructured":"Takiishi T, Gysemans C, Bouillon R, Mathieu C, 2010 Vitamin D and diabetes. Endocrinol Metab Clin North Am 39: 419\u2013446.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"BF03401332_CR13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12018-009-9033-y","volume":"7","author":"DD Bikle","year":"2009","unstructured":"Bikle DD, 2009 Extra renal synthesis of 1,25 dihydroxy vitamin D and its health implications. Clin Rev Bone Miner Metab 7: 114\u2013125.","journal-title":"Clin Rev Bone Miner Metab"},{"key":"BF03401332_CR14","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1210\/endo.134.4.8137744","volume":"134","author":"A Nishimura","year":"1994","unstructured":"Nishimura A, Shinki T, Jin CH, et al, 1994 Regulation of messenger ribonucleic acid expression of 1 alpha,25-dihydroxyvitamin D3-24-hydroxylase in rat osteoblasts. Endocrinology 134: 794\u20131799.","journal-title":"Endocrinology"},{"key":"BF03401332_CR15","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1172\/JCI30142","volume":"117","author":"J Schauber","year":"2007","unstructured":"Schauber J, Dorschner RA, Coda AB, et al, 2007 Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 117: 803\u2013811.","journal-title":"J Clin Invest"},{"key":"BF03401332_CR16","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1210\/er.2004-0002","volume":"26","author":"S Nagpal","year":"2005","unstructured":"Nagpal S, Na S, Rathnachalam R, 2005 Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26: 662\u2013687.","journal-title":"Endocr Rev"},{"key":"BF03401332_CR17","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.4049\/jimmunol.179.3.1634","volume":"179","author":"S Chen","year":"2007","unstructured":"Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE, 2007 Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179: 1634\u20131647.","journal-title":"J Immunol"},{"key":"BF03401332_CR18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11914-009-0011-6","volume":"7","author":"DD Bikle","year":"2009","unstructured":"Bikle DD, 2009 Vitamin D and immune function: Understanding common pathways. Curr Osteoporos Rep 7: 58\u201363.","journal-title":"Curr Osteoporos Rep"},{"key":"BF03401332_CR19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0006-291X(83)91544-9","volume":"117","author":"H Tanaka","year":"1983","unstructured":"Tanaka H, Abe E, Miyaura C, Shiina Y, Suda T, 1983 1-alpha,25-dihydroxyvitamin D3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytes. Biochem Biophys Res Commun 117: 86\u201392.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF03401332_CR20","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1126\/science.1123933","volume":"311","author":"PT Liu","year":"2006","unstructured":"Liu PT, Stenger S, Li H, et al, 2006 Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770\u20131773.","journal-title":"Science"},{"key":"BF03401332_CR21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.23.021704.115633","volume":"23","author":"YJ Liu","year":"2005","unstructured":"Liu YJ, 2005 IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23: 275\u2013306.","journal-title":"Annu Rev Immunol"},{"key":"BF03401332_CR22","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4049\/jimmunol.154.2.536","volume":"154","author":"JC Guery","year":"1995","unstructured":"Guery JC, Adorini L, 1995 Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells. J Immunol 154: 536\u2013544.","journal-title":"J Immunol"},{"key":"BF03401332_CR23","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.2113314","volume":"248","author":"RH Schwartz","year":"1990","unstructured":"Schwartz RH, 1990 A cell culture model for T lymphocyte clonal anergy. Science 248: 1349\u20131356.","journal-title":"Science"},{"key":"BF03401332_CR24","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.4049\/jimmunol.164.5.2405","volume":"164","author":"G Penna","year":"2000","unstructured":"Penna G, Adorini L, 2000 1-Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164: 2405\u20132411.","journal-title":"J Immunol"},{"key":"BF03401332_CR25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/eji.200425995","volume":"36","author":"K Sadeghi","year":"2006","unstructured":"Sadeghi K, Wessner B, Laggner U, et al, 2006 Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 36: 361\u2013371.","journal-title":"Eur J Immunol"},{"key":"BF03401332_CR26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaut.2004.06.004","volume":"23","author":"AG Halteren van","year":"2004","unstructured":"van Halteren AG, Tysma OM, van Etten E, Mathieu C, Roep BO, 2004 1-alpha,25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis. J Autoimmun 23: 233\u2013239.","journal-title":"J Autoimmun"},{"key":"BF03401332_CR27","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1006\/bbrc.2000.2490","volume":"270","author":"MD Griffin","year":"2000","unstructured":"Griffin MD, Lutz WH, Phan VA, et al, 2000 Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun 270: 701\u2013708.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF03401332_CR28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1172\/JCI111465","volume":"74","author":"JM Lemire","year":"1984","unstructured":"Lemire JM, Adams JS, Sakai R, Jordan SC, 1984 1-alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 74: 657\u2013661.","journal-title":"J Clin Invest"},{"key":"BF03401332_CR29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.tem.2005.06.004","volume":"16","author":"C Mathieu","year":"2005","unstructured":"Mathieu C, Badenhoop K, 2005 Vitamin D and type 1 diabetes mellitus: state of the art. Trends Endocrinol Metab 16: 261\u2013266.","journal-title":"Trends Endocrinol Metab"},{"key":"BF03401332_CR30","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.4049\/jimmunol.177.9.6030","volume":"177","author":"KM Spach","year":"2006","unstructured":"Spach KM, Nashold FE, Dittel BN, Hayes CE, 2006 IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J Immunol 177: 6030\u20136037.","journal-title":"J Immunol"},{"key":"BF03401332_CR31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0008-8749(90)90110-D","volume":"127","author":"S Iho","year":"1990","unstructured":"Iho S, Iwamoto K, Kur AF, Okuno Y, Takahashi T, Hoshino T, 1990 Mechanism in 1,25(OH)2D3-induced suppression of helper\/suppressor function of CD4\/CD8 cells to immunoglobulin production in B cells. Cell Immunol 127: 12\u201325.","journal-title":"Cell Immunol"},{"key":"BF03401332_CR32","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.4049\/jimmunol.167.9.4974","volume":"167","author":"A Boonstra","year":"2001","unstructured":"Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O\u2019Garra A, 2001 1alpha,25-Dihydroxyvitamin D3 has a direct effect on naive CD4(1) T cells to enhance the development of Th2 cells. J Immunol 167: 4974\u20134980.","journal-title":"J Immunol"},{"key":"BF03401332_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2220\/biomedres.27.1","volume":"27","author":"I Imazeki","year":"2006","unstructured":"Imazeki I, Matsuzaki J, Tsuji K, Nishimura T, 2006 Immunomodulating effect of vitamin D3 derivatives on type-1 cellular immunity. Biomed Res 27: 1\u20139.","journal-title":"Biomed Res"},{"key":"BF03401332_CR34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jsbmb.2005.06.002","volume":"97","author":"E Etten van","year":"2005","unstructured":"van Etten E, Mathieu C, 2005 Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 97: 93\u2013101.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BF03401332_CR35","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2337\/diabetes.49.8.1301","volume":"49","author":"L Overbergh","year":"2009","unstructured":"Overbergh L, Decallonne B, Waer M, et al, 2009 1alpha,25-dihydroxyvitamin D3 induces an autoantigen specific T-helper 1\/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524\u2013543). Diabetes 49: 1301\u20131307.","journal-title":"Diabetes"},{"key":"BF03401332_CR36","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.smim.2007.10.007","volume":"19","author":"T Korn","year":"2007","unstructured":"Korn T, Oukka M, Kuchroo V, Bettelli E, 2007 Th17 cells: effector T cells with inflammatory properties. Semin Immunol 19: 362\u2013371.","journal-title":"Semin Immunol"},{"key":"BF03401332_CR37","first-page":"1428","volume":"331","author":"MA Atkinson","year":"1995","unstructured":"Atkinson MA, Maclaren NK, 1995 The pathogenesis of insulin-dependent diabetes mellitus. Engl J Med 331: 1428\u20131436.","journal-title":"Engl J Med"},{"key":"BF03401332_CR38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/path.1711650203","volume":"165","author":"AK Foulis","year":"1991","unstructured":"Foulis AK, McGill M, Farquharson MA, 1991 Insulitis in type 1 (insulin-dependent) diabetes mellitus in man\u2014macrophages, lymphocytes, and interferon-gamma containing cells. J Pathol 165: 97\u2013103.","journal-title":"J Pathol"},{"key":"BF03401332_CR39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1677\/joe.0.1690161","volume":"169","author":"R Riachy","year":"2001","unstructured":"Riachy R, Vandewalle B, Belaich S, et al, 2001 Beneficial effect of 1,25 dihydroxyvitamin D3 on cytokine-treated human pancreatic islets. J Endocrinol 169: 161\u2013168.","journal-title":"J Endocrinol"},{"key":"BF03401332_CR40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1099-0895(199603)12:1<57::AID-DMR157>3.0.CO;2-L","volume":"12","author":"D Mauricio","year":"1996","unstructured":"Mauricio D, Mandrup-Poulsen T, Nerup J, 1996 Vitamin D analogues in insulin-dependent diabetes mellitus and other autoimmune diseases: a therapeutic perspective. Diabetes Metab Rev 12: 57\u201368.","journal-title":"Diabetes Metab Rev"},{"key":"BF03401332_CR41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/er.2007-0015","volume":"29","author":"DL Eizirik","year":"2008","unstructured":"Eizirik DL, Cardozo AK, Cnop M, 2008 The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 29: 42\u201361.","journal-title":"Endocr Rev"},{"key":"BF03401332_CR42","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/S0041-1345(97)00273-X","volume":"29","author":"HJ Hahn","year":"1997","unstructured":"Hahn HJ, Kuttler B, Mathieu C, Bouillon R, 1997 1,25-Di-hydroxyvitamin D3 reduces MHC antigen expression on pancreatic beta-cells in vitro. Transplant Proc 29: 2156\u20132157.","journal-title":"Transplant Proc"},{"key":"BF03401332_CR43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10495-006-3558-z","volume":"11","author":"R Riachy","year":"2006","unstructured":"Riachy R, Vandewalle B, Moerman E, et al, 2006 1,25-Di-hydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the Fas receptor. Apoptosis 11: 151\u2013159.","journal-title":"Apoptosis"},{"key":"BF03401332_CR44","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00125-008-1061-5","volume":"51","author":"SB Mohr","year":"2008","unstructured":"Mohr SB, Garland CF, Gorham ED, Garland FC, 2008 The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 51: 1391\u20131398.","journal-title":"Diabetologia"},{"key":"BF03401332_CR45","first-page":"1367","volume":"51","author":"K Casteels","year":"1998","unstructured":"Casteels K, Waer M, Laureys J, et al, 1998 Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine. Diabetes 51: 1367\u20131374.","journal-title":"Diabetes"},{"key":"BF03401332_CR46","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s00223-004-0118-9","volume":"75","author":"J Pino-Montes Del","year":"2004","unstructured":"Del Pino-Montes J, Benito GE, Fernandez-Salazar MP, et al, 2004 Calcitriol improves streptozotocin-induced diabetes and recovers bone mineral density in diabetic rats. Calcif Tissue Int 75: 526\u2013532.","journal-title":"Calcif Tissue Int"},{"key":"BF03401332_CR47","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/00007890-199805150-00014","volume":"65","author":"K Casteels","year":"1998","unstructured":"Casteels K, Waer M, Laureys J, et al, 1998 Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine. Transplantation 65: 1225\u20131232.","journal-title":"Transplantation"},{"key":"BF03401332_CR48","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/adc.2007.128579","volume":"93","author":"CS Zipitis","year":"2008","unstructured":"Zipitis CS, Akobeng AK, 2008 Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 93: 512\u2013517.","journal-title":"Arch Dis Child"},{"key":"BF03401332_CR49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s001250051112","volume":"42","author":"The EURODIAB Substudy 2 Study Group","year":"1999","unstructured":"Vitamin D supplementation in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group 1999 Diabetologia 42: 51\u201354.","journal-title":"Diabetologia"},{"key":"BF03401332_CR50","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0140-6736(99)07125-1","volume":"355","author":"EURODIAB ACE Study Group","year":"2000","unstructured":"EURODIAB ACE Study Group, 2000 Variation and trends in incidence of childhood diabetes in Europe. Lancet 355: 873\u2013876.","journal-title":"Lancet"},{"issue":"Suppl 3","key":"BF03401332_CR51","first-page":"31","volume":"76","author":"R Lorini","year":"2005","unstructured":"Lorini R, Minicucci L, Napoli F, et al, 2005 Screening for type 1 diabetes genetic risk in newborns of continental Italy. Primary prevention (Prevefin Italy)\u2014preliminary data. Acta Biomed 76(Suppl 3): 31\u201335.","journal-title":"Acta Biomed"},{"key":"BF03401332_CR52","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/dmrr.977","volume":"25","author":"X Li","year":"2009","unstructured":"Li X, Liao L, Yan X, et al, 2009 Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes. (LADA). Diabetes Metab Res Rev 25: 411\u2013416.","journal-title":"Diabetes Metab Res Rev"},{"key":"BF03401332_CR53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1399-5448.2006.00223.x","volume":"8","author":"HK Brekke","year":"2007","unstructured":"Brekke HK, Ludvigsson J, 2007 Vitamin D supplementation and diabetes-related autoimmunity in the ABIS study. Pediatr Diabetes 8: 11\u201314.","journal-title":"Pediatr Diabetes"},{"key":"BF03401332_CR54","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/dmrr.1276","volume":"27","author":"G Bock","year":"2011","unstructured":"Bock G, Prietl B, Mader JK, et al, 2011 The effect of vitamin D supplementation on peripheral regulatory T cells and \u03b2 cell function in healthy humans: a randomized controlled trial. Diabetes Metab Res Rev 27: 942\u2013945.","journal-title":"Diabetes Metab Res Rev"},{"key":"BF03401332_CR55","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archpediatrics.2012.164","volume":"166","author":"MA Gabbay","year":"2012","unstructured":"Gabbay MA, Sato MN, Finazzo C, Duarte AJ, Dib SA, 2012 Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual \u03b2-cell function in new-onset type 1 diabetes mellitus. Arch Pediatr Adolesc Med 166: 601\u2013607.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"BF03401332_CR56","doi-asserted-by":"crossref","first-page":"454","DOI":"10.4103\/0256-4947.72265","volume":"30","author":"KS Aljabri","year":"2010","unstructured":"Aljabri KS, Bokhari SA, Khan MJ, 2010 Glycemic changes after vitamin D supplementation in patients with type 1 diabetes mellitus and vitamin D deficiency. Ann Saudi Med 30: 454\u2013458.","journal-title":"Ann Saudi Med"},{"key":"BF03401332_CR57","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.2337\/dc10-0814","volume":"33","author":"C Bizzarri","year":"2010","unstructured":"Bizzarri C, Pitocco D, Napoli N, IMDIAB Group, et al, 2010 No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial. Diabetes Care 33: 1962\u20131963.","journal-title":"Diabetes Care"},{"key":"BF03401332_CR58","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2337\/dc09-2297","volume":"33","author":"M Walter","year":"2010","unstructured":"Walter M, Kaupper T, Adler K, Foersch J, Bonifacio E, Ziegler AG, 2010 No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes. Diabetes Care 33: 1443\u20131448.","journal-title":"Diabetes Care"},{"key":"BF03401332_CR59","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1464-5491.2006.01921.x","volume":"23","author":"D Pitocco","year":"2006","unstructured":"Pitocco D, Crin\u00f2 A, Di Stasio E, IMDIAB Group, et al, 2006 The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI). Diabet Med 23: 920\u2013923.","journal-title":"Diabet Med"},{"key":"BF03401332_CR60","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1210\/en.2006-0946","volume":"147","author":"AW Norman","year":"2006","unstructured":"Norman AW, 2006 Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 147: 5542\u20135548.","journal-title":"Endocrinology"},{"key":"BF03401332_CR61","doi-asserted-by":"crossref","unstructured":"Eliades M, Pittas AG, 2010 Vitamin D and type 2 diabetes. In Vitamin D Physiology, Molecular Biology and clinical applications ed. Holick M F. Humana press: pp, 895\u2013920.","DOI":"10.1007\/978-1-60327-303-9_49"},{"key":"BF03401332_CR62","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s007740050101","volume":"18","author":"T Fujita","year":"2000","unstructured":"Fujita T, Palmieri GM, 2000 Calcium paradox disease: calcium deficiency prompting secondary hyperparathyroidism and cellular calcium overload. J Bone Miner Metab 18: 109\u2013125.","journal-title":"J Bone Miner Metab"},{"key":"BF03401332_CR63","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/PL00010637","volume":"18","author":"T Fujita","year":"2000","unstructured":"Fujita T, 2000 Calcium paradox: consequences of calcium deficiency manifested by a wide variety of diseases. J Bone Miner Metab 18: 234\u2013236.","journal-title":"J Bone Miner Metab"},{"key":"BF03401332_CR64","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jmb.2005.03.060","volume":"349","author":"TW Dunlop","year":"2005","unstructured":"Dunlop TW, V\u00e4is\u00e4nen S, Frank C, Moln\u00e1r F, Sinkkonen L, Carlberg C, 2005 The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor. J Mol Biol 349: 248\u2013260.","journal-title":"J Mol Biol"},{"key":"BF03401332_CR65","doi-asserted-by":"crossref","first-page":"E345","DOI":"10.1152\/ajpendo.00456.2007","volume":"294","author":"Y Wei","year":"2008","unstructured":"Wei Y, Sowers JR, Clark S.E, Li W, Ferrario CM, Stump CS, 2008 Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase. Am J Physiol Endocrinol Metab 294: E345\u2013351.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BF03401332_CR66","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2337\/diabetes.51.5.1367","volume":"51","author":"S Gregori","year":"2002","unstructured":"Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L, 2002 1alpha,25-dihydroxyvitamin D3 analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 51: 1367\u20131374.","journal-title":"Diabetes"},{"key":"BF03401332_CR67","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2337\/diab.35.7.771","volume":"35","author":"BS Chertow","year":"1986","unstructured":"Chertow BS, Sivitz WI, Baranetsky NG, Cordle MB, DeLuca HF, 1986 Islet insulin release and net calcium retention in vitro in vitamin D-deficient rats. Diabetes 35: 771\u2013775.","journal-title":"Diabetes"},{"key":"BF03401332_CR68","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1210\/endo-120-4-1490","volume":"120","author":"C Cade","year":"1987","unstructured":"Cade C, Norman AW, 1987 Rapid normalization\/stimulation by 1,25-dihydroxyvitamin D3 of insulin secretion and glucose tolerance in the vitamin D-deficient rat. Endocrinology 120: 1490\u20131497.","journal-title":"Endocrinology"},{"key":"BF03401332_CR69","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.6250216","volume":"209","author":"AW Norman","year":"1980","unstructured":"Norman AW, Frankel JB, Heidt AM, Grodsky GM, 1980 Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209: 823\u2013825.","journal-title":"Science"},{"key":"BF03401332_CR70","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1210\/jc.2007-0298","volume":"92","author":"AG Pittas","year":"2007","unstructured":"Pittas AG, Lau J, Hu FB, Dawson-Hughes B, 2007 The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92: 2017\u20132029.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03401332_CR71","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archinte.167.11.1159","volume":"167","author":"D Martins","year":"2007","unstructured":"Martins D, Wolf M, Pan D, et al, 2007 Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167: 1159\u20131165.","journal-title":"Arch Intern Med"},{"key":"BF03401332_CR72","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.2337\/diacare.27.12.2813","volume":"27","author":"R Scragg","year":"2004","unstructured":"Scragg R, Sowers M, Bell C, 2004 Third National Health and Nutrition Examination Survey. Serum 25-hydroxy \u2014 vitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27: 2813\u20132818.","journal-title":"Diabetes Care"},{"key":"BF03401332_CR73","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2337\/db07-1122","volume":"57","author":"E Hypp\u00f6nen","year":"2008","unstructured":"Hypp\u00f6nen E, Boucher BJ, Berry DJ, Power C, 2008 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 57: 298\u2013305.","journal-title":"Diabetes"},{"key":"BF03401332_CR74","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/ajcn\/79.5.820","volume":"79","author":"KC Chiu","year":"2004","unstructured":"Chiu KC, Chu A, Go VL, Saad MF, 2004 Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79: 820\u2013825.","journal-title":"Am J Clin Nutr"},{"key":"BF03401332_CR75","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1155\/2010\/351385","volume":"2010","author":"JA Alvarez","year":"2010","unstructured":"Alvarez JA, Ashraf A, 2010 Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol 2010: 351\u2013385.","journal-title":"Int J Endocrinol"},{"key":"BF03401332_CR76","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-2265.2005.02288.x","volume":"62","author":"AG Need","year":"2005","unstructured":"Need AG, O\u2019Loughlin PD, Horowitz M, Nordin BE, 2005 Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol (Oxf) 62: 738\u2013741.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03401332_CR77","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.2337\/diacare.28.12.2926","volume":"28","author":"S Liu","year":"2005","unstructured":"Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM, 2005 Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 28: 2926\u20132932.","journal-title":"Diabetes Care"},{"key":"BF03401332_CR78","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2337\/diacare.29.03.06.dc05-1961","volume":"29","author":"AG Pittas","year":"2006","unstructured":"Pittas AG, Dawson-Hughes B, Li T, et al, 2006 Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29: 650\u2013656.","journal-title":"Diabetes Care"},{"key":"BF03401332_CR79","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/EDE.0b013e318176b8ad","volume":"19","author":"P Knekt","year":"2008","unstructured":"Knekt P, Laaksonen M, Mattila C, et al, 2008 Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 19: 666\u2013671.","journal-title":"Epidemiology"},{"key":"BF03401332_CR80","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1463-1326.2012.01605.x","volume":"14","author":"SS Harris","year":"2012","unstructured":"Harris SS, Pittas AG, Palermo NJ, 2012 A randomized, placebo-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans. Diabetes Obes Metab 14: 789\u2013794.","journal-title":"Diabetes Obes Metab"},{"key":"BF03401332_CR81","first-page":"521","volume":"20","author":"MH Eftekhari","year":"2011","unstructured":"Eftekhari MH, Akbarzadeh M, Dabbaghmanesh MH, et al, 2011 Impact of treatment with oral calcitriol on glucose indices in type 2 diabetes mellitus patients. Asia Pac J Clin Nutr 20: 521\u2013526.","journal-title":"Asia Pac J Clin Nutr"},{"key":"BF03401332_CR82","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3945\/ajcn.111.011684","volume":"94","author":"J Mitri","year":"2011","unstructured":"Mitri J, Dawson-Hughes B, Hu FB, Pittas AG, 2011 Effects of vitamin D and calcium supplementation on pancreatic \u03b2 cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 94: 486\u2013494.","journal-title":"Am J Clin Nutr"},{"key":"BF03401332_CR83","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3945\/ajcn.110.007336","volume":"93","author":"B Nikooyeh","year":"2011","unstructured":"Nikooyeh B, Neyestani TR, Farvid M, et al, 2011 Daily consumption of vitamin D-or vitamin D + calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr 93: 764\u2013771.","journal-title":"Am J Clin Nutr"},{"key":"BF03401332_CR84","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.1742-1241.2010.02372.x","volume":"64","author":"S Sabherwal","year":"2010","unstructured":"Sabherwal S, Bravis V, Devendra D, 2010 Effect of oral vitamin D and calcium replacement on glycaemic control in South Asian patients with type 2 diabetes. Int J Clin Pract 64: 1084\u20131089.","journal-title":"Int J Clin Pract"},{"key":"BF03401332_CR85","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1017\/S0007114509992017","volume":"103","author":"PR Hurst von","year":"2010","unstructured":"von Hurst PR, Stonehouse W, Coad J, 2010 Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient \u2014 a randomized, placebo-controlled trial. Br J Nutr 103: 549\u2013555.","journal-title":"Br J Nutr"},{"key":"BF03401332_CR86","doi-asserted-by":"crossref","first-page":"980","DOI":"10.2337\/dc06-1994","volume":"30","author":"AG Pittas","year":"2007","unstructured":"Pittas AG, Harris SS, Stark PC, Dawson-Hughes B, 2007 The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in non-diabetic adults. Diabetes Care 30: 980\u2013986.","journal-title":"Diabetes Care"},{"key":"BF03401332_CR87","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1742-1241.2003.tb10480.x","volume":"57","author":"AM Borissova","year":"2003","unstructured":"Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R, 2003 The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 57: 258\u2013261.","journal-title":"Int J Clin Pract"},{"key":"BF03401332_CR88","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/BF00422375","volume":"38","author":"BJ Boucher","year":"1995","unstructured":"Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJ, 1995 Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in East London Asians. Diabetologia 38: 1239\u20131245.","journal-title":"Diabetologia"},{"key":"BF03401332_CR89","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/ajcn\/59.5.1083","volume":"59","author":"E Orwoll","year":"1994","unstructured":"Orwoll E, Riddle M, Prince M, 1994 Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr 59: 1083\u20131087.","journal-title":"Am J Clin Nutr"},{"key":"BF03401332_CR90","first-page":"187","volume":"1","author":"S Inomata","year":"1986","unstructured":"Inomata S, Kadowaki S, Yamatani T, Fukase M, Fujita T, 1986 Effect of 1\u03b1(OH)-vitaminD3 on insulin secretion in diabetes mellitus. Bone Miner 1: 187\u2013192.","journal-title":"Bone Miner"},{"key":"BF03401332_CR91","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF02427083","volume":"29","author":"O Gedik","year":"1986","unstructured":"Gedik O, Akalin S, 1986 Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia 29: 142\u2013145.","journal-title":"Diabetologia"},{"key":"BF03401332_CR92","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF02427278","volume":"29","author":"BL Nyomba","year":"1986","unstructured":"Nyomba BL, Auwerx J, Bormans V, 1986 Pancreatic secretion in man with subclinical vitamin D deficiency. Diabetologia 29: 34\u201338.","journal-title":"Diabetologia"},{"key":"BF03401332_CR93","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s00125-010-1838-1","volume":"53","author":"MD Witham","year":"2010","unstructured":"Witham MD, Dove FJ, Dryburgh M, Sugden JA, Morris AD, Struthers AD, 2010 The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 53: 2112\u20132119.","journal-title":"Diabetologia"},{"key":"BF03401332_CR94","first-page":"462","volume":"267","author":"R Jorde","year":"2010","unstructured":"Jorde R, Sneve M, Torjesen P, Figenschau Y, 2010 No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern 267: 462\u2013472.","journal-title":"J Intern"},{"key":"BF03401332_CR95","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1753-0407.2009.00057.x","volume":"2","author":"P Patel","year":"2010","unstructured":"Patel P, Poretsky L, Liao E, 2010 Lack of effect of subtherapeutic vitamin D treatment on glycemic and lipid parameters in Type 2 diabetes: A pilot prospective randomized trial. J Diabetes 2: 36\u201340.","journal-title":"J Diabetes"},{"key":"BF03401332_CR96","doi-asserted-by":"crossref","first-page":"600","DOI":"10.4158\/EP09300.OR","volume":"16","author":"D Parekh","year":"2010","unstructured":"Parekh D, Sarathi V, Shivane VK, Bandgar TR, Menon PS, Shah NS, 2010 Pilot study to evaluate the effect of short-term improvement in vitamin D status on glucose tolerance in patients with type 2 diabetes mellitus. Endoer Pract 16: 600\u2013608.","journal-title":"Endoer Pract"},{"key":"BF03401332_CR97","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/ageing\/afp109","volume":"38","author":"A Avenell","year":"2009","unstructured":"Avenell A, Cook JA, Maclennan GS, Macpherson GC, RECORD trial group, 2009 Vitamin D supplementation and type 2 diabetes: a substudy of a randomized placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing 38: 606\u2013609.","journal-title":"Age Ageing"},{"key":"BF03401332_CR98","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00394-009-0020-3","volume":"48","author":"R Jorde","year":"2009","unstructured":"Jorde R, Figenschau Y, 2009 Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr 48: 349\u2013354.","journal-title":"Eur J Nutr"},{"key":"BF03401332_CR99","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1464-5491.2008.02636.x","volume":"26","author":"J Nagpal","year":"2009","unstructured":"Nagpal J, Pande JN, Bhartia A, 2009 A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 26: 19\u201327.","journal-title":"Diabet Med"},{"key":"BF03401332_CR100","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3945\/ajcn.2008.27004","volume":"89","author":"A Zittermann","year":"2009","unstructured":"Zittermann A, Frisch S, Berthold HK, et al, 2009 Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 89: 1321\u20131327.","journal-title":"Am J Clin Nutr"},{"key":"BF03401332_CR101","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/dc07-1829","volume":"31","author":"IH Boer de","year":"2008","unstructured":"de Boer IH, Tinker LF, Connelly S, et al, 2008 Women\u2019s Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women\u2019s Health Initiative. Diabetes Care 31: 701\u2013707.","journal-title":"Diabetes Care"},{"key":"BF03401332_CR102","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.nut.2008.04.009","volume":"24","author":"K Tai","year":"2008","unstructured":"Tai K, Need AG, Horowitz M, Chapman IM, 2008 Glucose tolerance and vitamin D: effects of treating vitamin D deficiency. Nutrition 24: 950\u2013956.","journal-title":"Nutrition"},{"key":"BF03401332_CR103","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1464-5491.2007.02360.x","volume":"25","author":"JA Sugden","year":"2008","unstructured":"Sugden JA, Davies JI, Witham MD, et al, 2008 Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med 25: 320\u2013325.","journal-title":"Diabet Med"},{"key":"BF03401332_CR104","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1365-2362.1997.1520699.x","volume":"27","author":"D Fliser","year":"1997","unstructured":"Fliser D, Stefanski A, Franek E, Fode P, Gudarzi A, Ritz E, 1997 No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. Eur J Clin Invest 27: 629\u2013633.","journal-title":"Eur J Clin Invest"},{"key":"BF03401332_CR105","first-page":"185","volume":"95","author":"I Zofkov\u00e1","year":"1990","unstructured":"Zofkov\u00e1 I, Stolba P, 1990 Effect of calcitriol and trifluoperazine on glucose stimulated B cell function in healthy humans. Exp Clin Endocrinol 95: 185\u2013191.","journal-title":"Exp Clin Endocrinol"},{"key":"BF03401332_CR106","first-page":"141","volume":"11","author":"L Lind","year":"1989","unstructured":"Lind L, Pollare T, Hvarfner A, Lithell H, S\u00f8rensen OH, Ljunghall S, 1989 Long-term treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance. Effects on insulin secretion and sensitivity, glucose tolerance and blood pressure. Diabetes Res 11: 141\u2013147.","journal-title":"Diabetes Res"},{"key":"BF03401332_CR107","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.0954-6820.1987.tb10684.x","volume":"222","author":"S Ljunghall","year":"1987","unstructured":"Ljunghall S, Lind L, Lithell H, et al, 1987 Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance. A prospective randomized double-blind study. Acta Med Scand 222: 361\u2013367.","journal-title":"Acta Med Scand"},{"key":"BF03401332_CR108","first-page":"407","volume":"8","author":"L Nilas","year":"1984","unstructured":"Nilas L, Christiansen C, 1984 Treatment with vitamin D or its analogues does not change body weight or blood glucose level in postmenopausal women. Int J Obes 8: 407\u2013411.","journal-title":"Int J Obes"},{"key":"BF03401332_CR109","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4158\/EP13273.OR","volume":"20","author":"CV Harinarayan","year":"2014","unstructured":"Harinarayan CV, Arvind S, Joshi S, Thennarasu K, Vedavyas V, Baindur A, 2014 Improvement in Pancreatic \u03b2 Cell Function with Vitamin D and Calcium Supplementation in Vitamin D Deficient Non-Diabetic Subjects. Endocr Pract 20: 129\u2013137.","journal-title":"Endocr Pract"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03401332\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03401332.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03401332.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T06:51:22Z","timestamp":1693810282000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03401332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":109,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["BF03401332"],"URL":"https:\/\/doi.org\/10.1007\/bf03401332","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}